Non-Alcoholic Fatty Liver Disease (NAFLD) Pathogenesis and Natural Products for Prevention and Treatment

Int J Mol Sci. 2022 Dec 7;23(24):15489. doi: 10.3390/ijms232415489.

Abstract

Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease, affecting approximately one-quarter of the global population, and has become a world public health issue. NAFLD is a clinicopathological syndrome characterized by hepatic steatosis, excluding ethanol and other definite liver damage factors. Recent studies have shown that the development of NAFLD is associated with lipid accumulation, oxidative stress, endoplasmic reticulum stress, and lipotoxicity. A range of natural products have been reported as regulators of NAFLD in vivo and in vitro. This paper reviews the pathogenesis of NAFLD and some natural products that have been shown to have therapeutic effects on NAFLD. Our work shows that natural products can be a potential therapeutic option for NAFLD.

Keywords: NAFLD; endoplasmic reticulum stress; lipid accumulation; lipotoxicity; natural products; oxidative stress; pathogenesis; plants.

Publication types

  • Review

MeSH terms

  • Biological Products* / metabolism
  • Biological Products* / pharmacology
  • Biological Products* / therapeutic use
  • Endoplasmic Reticulum Stress
  • Ethanol / metabolism
  • Humans
  • Liver / metabolism
  • Non-alcoholic Fatty Liver Disease* / drug therapy
  • Non-alcoholic Fatty Liver Disease* / etiology
  • Non-alcoholic Fatty Liver Disease* / prevention & control
  • Oxidative Stress

Substances

  • Biological Products
  • Ethanol